Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in Patients with colorectal cancerYAMAUE, Hiroki; TANIMURA, Hiroshi; KONO, Nobuji et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2559-2564, issn 0250-7005, 6 p.Article

Doxifluridine-induced neurotoxicity with normal dihydropyrimidine dehydrogenase activityDONG WOOK KIM; KIM, Han-Joon; KIM, Dong-Eog et al.Neurology. 2004, Vol 62, Num 11, pp 2136-2137, issn 0028-3878, 2 p.Article

Increased anticoagulant activity of warfarin used in combination with doxifluridineNAKAJIMA, Masaru; GENDA, Tomoo; SUEHIRA, Mayu et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 5, pp 969-972, issn 0344-5704, 4 p.Article

Comparison of average, scaled average, and population bioequivalence methods for assessment of highly variable drugs: An experience with doxifluridine in beagle dogsBAEK, In-Hwan; LEE, Byung-Yo; KANG, Wonku et al.European journal of pharmaceutical sciences. 2010, Vol 39, Num 1-3, pp 175-180, issn 0928-0987, 6 p.Article

Neurological manifestations in a phase 2 study of 13 patients treated with doxyfluridineHEIER, M. S; FOSSA, S. D.Acta neurologica scandinavica. 1985, Vol 72, Num 2, pp 171-175, issn 0001-6314Article

A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancerHYE WON CHUNG; SEUNG MIN BANG; SEUNG WOO PARK et al.International journal of radiation oncology, biology, physics. 2004, Vol 60, Num 5, pp 1494-1501, issn 0360-3016, 8 p.Article

Advanced gastric cancer with peritoneal dissemination successfully treated with paclitaxel and doxifluridine : A case reportTAKEYOSHI, Izumi; IWANAMI, Kotaro; MORISHITA, Yasuo et al.Hepato-gastroenterology. 2005, Vol 52, Num 61, pp 322-325, issn 0172-6390, 4 p.Article

Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year Versus 3 years after breast cancer surgery by the shimane breast cancer study groupAnticancer research. 2006, Vol 26, Num 1B, pp 591-597, issn 0250-7005, 7 p.Article

Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liverOZAWA, Shogo; HAMADA, Masashi; MURAYAMA, Norie et al.Cancer chemotherapy and pharmacology. 2002, Vol 50, Num 6, pp 454-458, issn 0344-5704, 5 p.Article

Toxicité de la doxifluridine, analogue peu myélosuppresseur du fluoro-uracile = Toxicity of doxifluridine, a fluoracil analog with a low myelosuppressive effectWINKELMANN, J. J; ALBERTO, P; MERMILLOD, B et al.Bulletin du cancer. 1990, Vol 77, Num 3, pp 225-234, issn 0007-4551, 10 p.Article

Uptake of doxifluridine by rabbit small intestinal brush-border membrane vesiclesKITAGAWA, S; HASEGAWA, M; SATO, S et al.Biological & pharmaceutical bulletin. 1998, Vol 21, Num 12, pp 1382-1384, issn 0918-6158Article

In vitro toxicity of N³-methyl-5'-deoxy-5-fluorouridine, a novel metabolite of doxifluridine : a bioanalytical investigationZAMBONIN, C. G; ARESTA, A; GRANO, M et al.Journal of pharmaceutical and biomedical analysis. 1998, Vol 17, Num 1, pp 11-16, issn 0731-7085Article

Determination of N³-methyl-5'-deoxy-5-fluorouridine, a novel metabolite of doxifluridine, in body fluids by high performance liquid chromatographyZAMBONIN, C. G; MASTROLITTI, S; PALMISANO, F et al.Journal of pharmaceutical and biomedical analysis. 1998, Vol 17, Num 2, pp 291-297, issn 0731-7085Article

Targeted drug delivery: a two-compartment growth inhibition assay demonstrates that fluorodeoxyuridine and fluorodeoxyuridine monophosphate are liposome-independent drugsHEATH, T. D; BROWN, C. S.Cancer drug delivery. 1989, Vol 5, Num 4, pp 179-184, issn 0732-9482Article

Irinotecan cytotoxicity does not necessarily depend on the UGT1A1 polymorphism but on fluoropyrimidine : A molecular case reportINOUE, Yasuhiro; MIKI, Chikao; WATANABE, Hideki et al.Oncology reports. 2006, Vol 16, Num 5, pp 971-974, issn 1021-335X, 4 p.Article

A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patientsTAKEYOSHI, Izumi; MAKITA, Fujio; SUNOSE, Yutaka et al.Anticancer research. 2005, Vol 25, Num 2B, pp 1291-1296, issn 0250-7005, 6 p.Article

Simultaneous determination of doxifluridine and 5-fluorouracil in monkey serum by high performance liquid chromatography with tandem mass spectrometryWOO, Young-Ah; KIM, Ghee-Hwan; EUN JU JEONG et al.Journal of chromatography. B. 2008, Vol 875, Num 2, pp 487-492, issn 1570-0232, 6 p.Article

Summaries of presented material/Experimental dand clinical studies on the anticancer agent, doxifluridine (5'-DFUR), symposium: 25th. annual meeting of the Japan Society for cancer Therapy, Sapporo, Japan, 7 October 1987KIMURA, K; SAITO, T; TAGUCHI, T et al.Journal of international medical research. Supplement. 1988, Vol 16, Num 2, issn 0142-2596, 39 p.Conference Proceedings

Detection of fluoropyrimidines and their metabolites in biological samples by fluorine-19 NMR: application to 5'-deoxy-5-fluorouridineMALET-MARTINO, M. C; MARTINO, R; LOPEZ, A et al.Biomedicine & pharmacotherapy. 1983, Vol 37, Num 7, pp 357-359, issn 0753-3322Article

Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancerYAKABE, Tomomi; NOSHIRO, Hirokazu; IKEDA, Osamu et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 10, pp 1499-1504, issn 0171-5216, 6 p.Article

Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancerKOIZUMI, Wasaburo; FUKUYAMA, Yoshio; FUKUDA, Takahiro et al.Anticancer research. 2004, Vol 24, Num 4, pp 2465-2470, issn 0250-7005, 6 p.Article

Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapyINOUE, Yasuhiro; SHIRANE, Masatoshi; MIKI, Chikao et al.International journal of oncology. 2004, Vol 25, Num 6, pp 1641-1649, issn 1019-6439, 9 p.Article

The potential for oral combination chemotherapy of 5'-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancerYOSHIMOTO, M; TADA, K; TOKUDOME, N et al.British journal of cancer. 2003, Vol 89, Num 9, pp 1627-1632, issn 0007-0920, 6 p.Article

Weekly Paclitaxel in Combination with Doxifluridine for Peritoneally Disseminated Gastric Cancer with Malignant AscitesTAKEYOSHI, Izumi; MAKITA, Fujio; KOBAYASHI, Isao et al.Anticancer research. 2011, Vol 31, Num 12, pp 4625-4630, issn 0250-7005, 6 p.Article

Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free intervalNISHIMURA, Reiki; TOMINAGA, Takeshi; KOGA, Toshihiro et al.Anticancer research. 2004, Vol 24, Num 3B, pp 2085-2091, issn 0250-7005, 7 p.Article